Aurora Cannabis (ACB) reported earnings Tue 22 Sept 20 (a/h)

 ** charts before earnings **

 

** charts after earnings **

Reported Q4 results. Total net revs fell 5% from the prior quarter to CAD$72.1 mln; consumer cannabis net revs decreased 9% over the previous quarter, impacted by a 30% decrease in the average net selling price per gram of consumer cannabis. Medical cannabis net revs increased +4% from the prior quarter. Adj. EBITDA was a loss of CAD$(34.6) mln. Co noted that is has "slipped from its top position in Canadian consumer"; co plans to execute certain tactical initiatives in the category to return to its leadership position. Moves to its lowest levels since May.

This week's biggest % winners & losers: May 11 - 15, 20 (wk 20)

This week's biggest % gainers/losers The following are this week's top percentage gainers and losers, categorized by sectors (over $300 mln market cap and 100K average daily volume)

This week's top % gainers

• Healthcare: NVAX (43.63 +132.94%), CBAY (4.05 +127.53%), MYOK (121.69 +99.2%), ALLO (44.91 +42.98%), ACB (11.2 +38.97%), CYTK (21.64 +37.35%), MDGL (118.4 +30.32%), NTLA (17.66 +29.47%), MGNX (25.8 +26.84%), OPK (2.62 +24.76%), QDEL (197.27 +24.38%), INO (13.43 +23.72%)
• Materials: CDE (5.1 +22.3%)
• Industrials: UPWK (13.72 +39.29%)
• Consumer Discretionary: SFIX (21.41 +21.58%)
• Information Technology: AVYA (13.2 +26.07%)
• Consumer Staples: UNFI (18.32 +53.18%)
• Utilities: CEPU (2.95 +21.9%)

This week's top % losers

• Healthcare: CTMX (9.01 -36.73%)
• Materials: SXC (2.58 -27.73%)
• Industrials: SALT (14.6 -27.22%)
• Information Technology: INFN (4.26 -29.82%)
• Financials: CLNC (3.81 -27.15%)
• Energy: FTSI (3.73 -44.86%), CRC (1.49 -37.13%), CRK (4.65 -36.82%), OMP (4.35 -33.18%), GPOR (1.62 -32.22%), CHK (10.79 -26.6%)
• Consumer Staples: COTY (3.29 -36.73%)

Aurora Cannabis (ACB) reported earnings on Thur 14 May 20 (a/h)

• 5/14:  #1, 29, 75; vol 12.2M

** charts after earnings **

Aurora Cannabis Earnings Miss in Q3, on Track for Positive Earnings by 2021

• Posts smaller sequential loss as pot use rises amid lockdown
• The Canadian pot producer sold 12,729 kilograms of cannabis in the third quarter, 39% more than a year earlier. The sales spike comes as cannabis is an essential service in several provinces and states across Canada and the Unites States.

Aurora Cannabis (NYSE:ACB) said it was on track to deliver positive earnings by next year after reporting mixed third-quarter results as earnings fell short, but revenue topped expectations as the marijuana producer ramped up production.

"I am also pleased that our third quarter 2020 financial results were in-line with our expectations and that we remain firmly on track with the cost-savings and capex goals we detailed during our business transformation plan in February 2020," said Michael Singer, executive chairman and interim chief executive of Aurora.

SG&A costs in the third quarter of 2020 were $75.1 million, down $24.7 million from the prior quarter.

Aurora Cannabis reported third-quarter losses of C$1.37 a share, missing estimates for a loss of C$0.77. Revenue of C$75.5 million beat estimates of C$46.99 million.

The beat on the top line was led by strong performance in its consumer cannabis business, with revenue up 24% to $41.5 million year on year.

Production volume rose 18% to 36,207 kilograms in the quarter.

** next 3 days **

Earnings this week : May 11 - 15, 20 (wk 20)

Monday (May 11)

• Morning: AMRX AN AVYA CAH CEVA CHH CLF CEIX CLR COTY EBIX ETR GOGO GBDC ICPT XENT MGLN MAR MYL ON ORA PK RDNT TERP UAA UNVR XHR ZBH
• Afternoon: TXG XLRN AIMT AMBC AMCR AEE AFG AMN BE BHF CABO CBT CZR CDLX CSOD DDOG DRH DIOD ERI ECPG ET ENSG ETH EB EXTR FATE FOE FBM G GDOT GSKY GO GWPH HALO HHC IIVI IPAR IFF JCOM KAMN LTHM LOGI MBI MESA MIME NHI NSA PLYA PTLA KWR REPH RETA RPAY SGMO SCSC SPG SUN TME TLRY

Tuesday (May 12)

• Morning: BNTX CVLT DUK DT FI HMC IR MAC NOVT FLOW TUFN VSH
• Afternoon: EGHT ADPT ALC ALGT NVST HCAT INFN OR PGNY RXN RLJ SWAV VREX 

Wednesday (May 13)

• Morning: CYBR PGTI TSEM
• Afternoon: ONEM CSCO FLO JACK NVGS OII SDC STE VRTU

Thursday (May 14)

• Morning: AZUL BAM AG GDS KEM NICE NCLH NVMI SPNS SSYS WNC WIX
• Afternoon: ACB AMAT CVET DENN FTCH GLOB GTBIF HBM NEWR NLOK SSRM

Friday (May 15) 

• Morning: JD PBF VFC

This week's biggest % winners & losers : Jan 13 - 17, 20 (wk 3)

The following are this week's top percentage gainers and losers, categorized by sectors (over $300 mln market cap and 100K average daily volume).

This week's top % gainers

• Healthcare: ADAP (4.52 +239.85%), MNK (5.2 +64.04%), MNTA (30.6 +61.39%), NVAX (5.74 +46.06%), CYH (3.43 +40.57%), RIGL (2.88 +38.46%), TLRY (20.97 +34.86%), ENDP (6.04 +32.75%), ACB (2.13 +29.09%), CRON (8.55 +25.92%), GRTS (11.23 +25.06%)
• Industrials: BLDP (12.04 +32.75%)
• Consumer Discretionary: SIG (29.52 +51.38%), NIO (4.67 +33.05%)
• Information Technology: INSG (9.15 +26.56%), ICHR (38.58 +25.5%)
• Energy: TELL (8.69 +27.98%)
• Consumer Staples: PRMW (14.67 +32.28%)
• Utilities: PCG (13.08 +28.24%)

This week's top % losers

• Healthcare: INGN (49.43 -19.19%), SIEN (7.65 -17.03%), NKTR (22.48 -16.49%), EXAS (88.06 -15.68%), INSM (21.46 -15.48%), RCKT (20.76 -13.61%), TCMD (60.82 -13.11%)
• Industrials: SALT (5.15 -14.31%)
• Consumer Discretionary: TLYS (8.56 -26.71%), TAST (5.39 -20.62%), MIK (6.4 -15.57%)
• Financials: QD (3.52 -19.08%)
• Energy: NINE (7.25 -22.04%), GPOR (1.9 -18.45%), RRC (3.96 -18.01%), FET (1.45 -13.69%)
• Consumer Staples: MGPI (38.18 -22.26%)

Long trade : Aurora Cannabis Inc. (ACB) +30%

• Jan 13: #4, 5, 26; vol. 47.1M
• Note:  Aurora Cannabis Inc. (NYSE: ACB) will be conducting a 1-for-12 reverse stock split on May 11.

• 3 months later 

-=Aurora Cannabis (ACB) reported earnings on Wed 11 Sept 19 (a/h)

Aurora Cannabis misses Q4 estimates 

Adjusted EBITDA loss of CAD$11.7 mln vs. (CAD$7.7 mln ests), represents an improvement of 68%; revenue +193% to CAD 98.9 mln vs. $103.5 mln consensus.

Net cannabis revenue up 61% sequentially to $94.6 million Canadian consumer cannabis revenue up 52% to $44.9 million Medical cannabis revenue up 10% to $29.7 million Wholesale revenues of $20.1 million. Cash cost to produce per gram sold declined 20% sequentially to $1.14 per gram in Q4 2019.

Production volume increased 86% sequentially to 29,034 kgs. Gross margin on cannabis net revenue increased by 3% to 58% sequentially.

The global cannabis and hemp markets represent a significant opportunity for Aurora and the Company will continue to make the necessary investments today to build long-term value for shareholders. However, Aurora will take a balanced approach to these investments with a focus on operating a sustainable and profitable business. The introduction of new product formats to the Canadian consumer market this fall represents a significant opportunity for the Company. Aurora expects to have a robust product line-up ready to launch in December. Given the very early stage of development of the consumer market in Canada and international medical markets, management anticipates that quarter to quarter sales volumes and revenues may be volatile.

The Company expects adjusted EBITDA to continue to improve in the future due to expected revenue growth, improvements in gross margin and prudent SG&A growth.

=Aurora Cannabis (ACB) reported earnings on Wed 15 May 2019 (b/o)

Aurora Cannabis misses by CAD0.05, misses on revs

• Reports Q3 (Mar) loss of CAD0.11 per share, CAD0.05 worse than the S&P Capital IQ Consensus of (CAD0.06); revenues rose 20.3% year/year to CAD65.2 mln vs the CAD67.5 mln S&P Capital IQ Consensus.
• Outlook
  • The Aurora Sky and Bradford facilities are now operating at full capacity. With this, the Company's annualized production run rate across its operational facilities is in excess of 150,000 kg per annum, based on planted rooms.
  • Aurora reiterates its target for Q4 with production available for sale in excess of 25,000 kg. Management intends to allocate a portion of this capacity to its inventory for manufacturing new products. Aurora remains focused on having vapes and certain edibles ready for launch under new regulations in the Canadian consumer market which are expected toward the end of the calendar year.

Earnings this week : May 13 - 17, 2019 (wk 20)

 

Monday (May 13)

• Premarket: CPRX    

• After-Hours:  BILI HOLI IIIV IMMR KRNT LM MIME NVGS STE STNE TME TTWO

Tuesday (May 14)

• Premarket:  AZZ BEST CTST CYBR GDS HUD MIXT RL TAK

• After hours:  A ACB DOX EGHT FSM NEWR PAGS TCS TLRY

Wednesday (May 15)

• Premarket:  BABA ERJ M PLCE PPDF RUBY TSEM TSG
• After hours:  CSCO DDS FLO FTCH JACK NTES TRQ VRTU ZTO

Thursday (May 16)

• Premarket:  AZZ EXP FRO KEM MANU MMYT NICE QIWI WIX WMT

• After hours:  BOOT AINV AMAT NVDA BIDU IQ HUYA PINS

Friday (May 17)

• Premarket:  CAE DE LX
• After hours:  

=Aurora Cannabis (ACB) to acquire Farmacias Magistrales

Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange as ACB. As of late September 2018, Aurora Cannabis had eight licensed production facilities, five sales licenses, and operations in 18 countries.
Revenue: 18 million CAD (2017)
Headquarters: Vancouver, Canada
auroramj.com



As previously announced, Farmacias recently became Mexico's first and only federally licensed importer to date of raw materials containing THC, gaining the necessary licenses, facilities, and permissions to import raw THC material, and manufacture, store, and distribute medical cannabis products containing over 1% THC.

• Consideration to be paid for the acquisition of Farmacias will be in shares of Aurora and based on a valuation of the proforma distribution revenue projections of Farmacias. The consideration payable by Aurora also includes a contingent portion of up to 25% payable only upon the achievement of certain milestones over the next 12 months related to operational metrics, such as maintaining market share.